Compare BN Agrochem with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.71
- The company has reported losses. Due to this company has reported negative ROCE
Risky - Negative EBITDA
Despite the size of the company, domestic mutual funds hold only 0% of the company
Stock DNA
Trading & Distributors
INR 2,371 Cr (Small Cap)
123.00
NA
0.00%
0.18
4.45%
5.48
Total Returns (Price + Dividend) 
BN Agrochem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

BN Agrochem Ltd Hits Intraday Low Amidst Significant Price Pressure
Shares of BN Agrochem Ltd experienced significant intraday weakness on 4 Mar 2026, touching a low of Rs 235, down 8.19% from previous levels, reflecting pronounced price pressure amid broader market volatility and sector underperformance.
Read full news article
BN Agrochem Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
BN Agrochem Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a mildly bearish outlook as of early March 2026. Despite a 3.5% gain on the day, the company’s technical indicators present a complex picture, with bearish signals dominating weekly and monthly charts, raising questions about the stock’s near-term trajectory amid broader market volatility.
Read full news article
BN Agrochem Ltd Downgraded to Strong Sell Amid Technical Weakness and Financial Concerns
BN Agrochem Ltd, a player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 2 March 2026. This revision reflects a deterioration in technical indicators alongside persistent financial challenges, despite recent positive sales growth. The company’s Mojo Score has dropped to 23.0, signalling heightened caution for investors amid mixed performance across quality, valuation, financial trends, and technical parameters.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Feb-2026 | Source : BSEPursuant to Regulation 30 of SEBI (LODR) 2015 please find attached herewith intimation of publication of financial results for the third quarter and nine months ended December 31 2025 in newspaper.
Results-Financial Results For December 31 2025
13-Feb-2026 | Source : BSEPursuant to Regulation 30 read with regulation 33 of SEBI (LODR) 2015 please find attached un-audited Standalone & Consolidated for the third quarter ended December 31 2025.
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held On February 13 2026
13-Feb-2026 | Source : BSEOutcome of Board Meeting inter-alia to consider and approve un-audited Standalone and Consolidated financial results for third quarter and nine months ended December 31 2025.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.0%)
Anubhav Agarwal (5.93%)
Global Focus Fund (18.34%)
3.25%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 125.44% vs 0.00% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -167.20% vs 900.79% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 599.34% vs -692.71% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 618.05% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 1,158.87% vs 211.71% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 4,122.99% vs 0.00% in Mar 2024
YoY Growth in year ended Mar 2025 is 731.31% vs -745.95% in Mar 2024






